{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:55:41Z","timestamp":1718877341105},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.2515\/therapie\/2011061","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T13:55:39Z","timestamp":1319637339000},"page":"437-443","source":"Crossref","is-referenced-by-count":2,"title":["Mise au point sur les antithrombotiques et la grossesse"],"prefix":"10.1016","volume":"66","author":[{"given":"C\u00e9line","family":"Chauleur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Gris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Seffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Mismetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2011061_bb0005","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"457","key":"10.2515\/therapie\/2011061_bb0010","first-page":"e1","article-title":"Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes","volume":"197","author":"Duhl","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.2515\/therapie\/2011061_bb0015","first-page":"1","article-title":"Thrombophilie et grossesse","author":"Conf\u00e9rence de consensus","year":"2003","journal-title":"ANAES"},{"key":"10.2515\/therapie\/2011061_bb0020","article-title":"Thromboembolic disease in pregnancy-green-top No 28 February -Version. Guideline No 28 1 of 17 Thromboembolic disease in pregnancy","author":"Thomson","year":"2007","journal-title":"Advances in low molecular weight"},{"key":"10.2515\/therapie\/2011061_bb0025","article-title":"Recommandations pour la pratique clinique de la Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation : pr\u00e9vention de la maladie thromboembolique veineuse p\u00e9ri op\u00e9ratoire et obst\u00e9tricale","author":"Conf\u00e9rence de consensus","year":"2005","journal-title":"ANAES"},{"key":"10.2515\/therapie\/2011061_bb0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ccm.2010.06.004","article-title":"Venous thromboembolism in pregnancy","volume":"31","author":"Marik","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.2515\/therapie\/2011061_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/01443610600720253","article-title":"A survey of pregnant women on the use of graduated elastic compression stockings on the antenatal ward","volume":"26","author":"Gray","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"10.2515\/therapie\/2011061_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2006.03.008","article-title":"Interventions for leg edema and varicosities in pregnancy. What evidence?","volume":"129","author":"Bamigboye","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.2515\/therapie\/2011061_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2007.01.002","article-title":"Hyperhomocysteinemia and venous thrombosis","volume":"44","author":"Gatt","year":"2007","journal-title":"Semin Hematol"},{"key":"10.2515\/therapie\/2011061_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial","volume":"109","author":"den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.2515\/therapie\/2011061_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004659.pub2","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.2515\/therapie\/2011061_bb0060","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2011061_bb0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a metaanalysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.2515\/therapie\/2011061_bb0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 2)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.2515\/therapie\/2011061_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/bmj.326.7379.37","article-title":"Antithrombotic therapy in special circumstances. I\u2013pregnancy and cancer","volume":"326","author":"Jilma","year":"2003","journal-title":"BMJ"},{"key":"10.2515\/therapie\/2011061_bb0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/GCO.0b013e3282f10e33","article-title":"The use of low-molecular-weight heparins in pregnancy\u2013how safe are they?","volume":"19","author":"Deruelle","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.2515\/therapie\/2011061_bb0085","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.325.7370.948","article-title":"ABC of antithrombotic therapy: venous thromboembolism: treatment strategies","volume":"325","author":"Turpie","year":"2002","journal-title":"BMJ"},{"key":"10.2515\/therapie\/2011061_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11239-006-5578-5","article-title":"Anticoagulants in pregnancy","volume":"21","author":"Greer","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.2515\/therapie\/2011061_bb0095","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","article-title":"Heparin therapy during pregnancy. Risks to the fetus and mother","volume":"149","author":"Ginsberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie\/2011061_bb0100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(09)60996-X","article-title":"Pulmonary embolism in pregnancy","volume":"375","author":"Bourjeily","year":"2010","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2011061_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.2515\/therapie\/2011061_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00016340903370098","article-title":"Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin","volume":"89","author":"Andersen","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.2515\/therapie\/2011061_bb0115","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.2515\/therapie\/2011061_bb0120","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0049-3848(09)70010-6","article-title":"Treatment of venous thromboembolism during pregnancy","volume":"123","author":"Bauersachs","year":"2009","journal-title":"Thromb Res"},{"key":"10.2515\/therapie\/2011061_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007801.pub2","article-title":"Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy","author":"Che Yaakob","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.2515\/therapie\/2011061_bb0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00428-010-0982-9","article-title":"Warfarin embryopathy: fetal manifestations","volume":"457","author":"Wainwright","year":"2010","journal-title":"Virchows Arch"},{"key":"10.2515\/therapie\/2011061_bb0135","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-0037-1615641","article-title":"Coumarins during pregnancy: long-term effects on growth and development of school-age children","volume":"85","author":"Wesseling","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie\/2011061_bb0140","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","article-title":"Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Bates","year":"2004","journal-title":"Chest"},{"key":"10.2515\/therapie\/2011061_bb0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1160\/TH06-02-0108","article-title":"Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study","volume":"95","author":"Schaefer","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie\/2011061_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.thromres.2009.06.006","article-title":"An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran)","volume":"125","author":"Magnani","year":"2010","journal-title":"Thromb Res"},{"key":"10.2515\/therapie\/2011061_bb0155","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","article-title":"Minor transplacental passage of fondaparinux in vivo","volume":"350","author":"Dempfle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie\/2011061_bb0160","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1182\/blood-2006-03-009548","article-title":"Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy","volume":"108","author":"Mazzolai","year":"2006","journal-title":"Blood"},{"key":"10.2515\/therapie\/2011061_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.mbc.0000214710.19116.40","article-title":"Fondaparinux as anticoagulant in a pregnant woman with heparin allergy","volume":"17","author":"Wijesiriwardana","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.2515\/therapie\/2011061_bb0170","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1538-7836.2010.03926.x","article-title":"Fondaparinux as an alternative anticoagulant therapy during pregnancy","volume":"8","author":"Knol","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.2515\/therapie\/2011061_bb0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0897.2009.00733.x","article-title":"A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss","volume":"62","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.2515\/therapie\/2011061_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.thromres.2006.03.008","article-title":"Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy","volume":"119","author":"Harenberg","year":"2007","journal-title":"Thromb Res"},{"key":"10.2515\/therapie\/2011061_bb0185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1160\/TH06-10-0577","article-title":"Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids","volume":"97","author":"Gerhardt","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie\/2011061_bb0190","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1378\/chest.127.2_suppl.1S","article-title":"The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy","volume":"127","author":"Hassell","year":"2005","journal-title":"Chest"},{"key":"10.2515\/therapie\/2011061_bb0195","first-page":"ECR40","article-title":"Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report","volume":"91","author":"Furlan","year":"2006","journal-title":"Haematologica"},{"key":"10.2515\/therapie\/2011061_bb0200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijoa.2009.01.012","article-title":"Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia","volume":"19","author":"Ekbatani","year":"2010","journal-title":"Int J Obstet Anesth"},{"key":"10.2515\/therapie\/2011061_bb0205","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1592\/phco.28.12.1531","article-title":"Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature","volume":"28","author":"Young","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.2515\/therapie\/2011061_bb0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/AOG.0b013e31817788e0","article-title":"Lepirudin for treatment of acute thrombosis during pregnancy","volume":"112","author":"Chapman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.2515\/therapie\/2011061_bb0215","first-page":"202","article-title":"Pharmacological survey of recombinant hirudin","volume":"43","author":"Markwardt","year":"1988","journal-title":"Pharmazie"},{"key":"10.2515\/therapie\/2011061_bb0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-006-5709-z","article-title":"Thrombolytic therapy in pregnancy","volume":"21","author":"Leonhardt","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.2515\/therapie\/2011061_bb0225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1076029609335517","article-title":"Fibrinolytic therapy of prosthetic mitral valve thrombosis during pregnancy: three case reports and review of the literature","volume":"16","author":"Ozer","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.2515\/therapie\/2011061_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2009.03.001","article-title":"Treatment options in massive pulmonary embolism during pregnancy; a case-report and review of literature","volume":"124","author":"te Raa","year":"2009","journal-title":"Thromb Res"},{"key":"10.2515\/therapie\/2011061_bb0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716307958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716307958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T04:24:50Z","timestamp":1713068690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716307958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0040595716307958"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2011061","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}